HealthEquity, Inc. (NASDAQ:HQY) Receives Average Recommendation of “Buy” from Analysts

Shares of HealthEquity, Inc. (NASDAQ:HQY) have received a consensus rating of “Buy” from the thirteen research firms that are presently covering the company, MarketBeat reports. One analyst has rated the stock with a hold rating, eleven have given a buy rating and one has issued a strong buy rating on the company. The average 12 month price target among brokerages that have issued a report on the stock in the last year is $112.23.

Several analysts recently issued reports on HQY shares. Raymond James upgraded shares of HealthEquity from an “outperform” rating to a “strong-buy” rating and reduced their price target for the stock from $120.00 to $115.00 in a research report on Tuesday. KeyCorp cut their target price on HealthEquity from $120.00 to $110.00 and set an “overweight” rating for the company in a research note on Monday. JMP Securities boosted their price target on HealthEquity from $105.00 to $107.00 and gave the stock a “market outperform” rating in a report on Tuesday, December 10th. Wells Fargo & Company upped their price target on shares of HealthEquity from $110.00 to $125.00 and gave the stock an “overweight” rating in a report on Wednesday, February 26th. Finally, Royal Bank of Canada lifted their price target on shares of HealthEquity from $100.00 to $105.00 and gave the stock an “outperform” rating in a report on Tuesday, December 10th.

Insider Buying and Selling

In other HealthEquity news, Director Robert W. Selander sold 5,750 shares of the company’s stock in a transaction on Monday, February 10th. The shares were sold at an average price of $111.29, for a total transaction of $639,917.50. Following the transaction, the director now owns 78,219 shares in the company, valued at approximately $8,704,992.51. This represents a 6.85 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. 2.20% of the stock is owned by company insiders.

Institutional Investors Weigh In On HealthEquity

A number of institutional investors and hedge funds have recently made changes to their positions in HQY. Holocene Advisors LP bought a new stake in HealthEquity during the 3rd quarter worth approximately $1,246,000. Loomis Sayles & Co. L P boosted its holdings in HealthEquity by 2.2% during the 3rd quarter. Loomis Sayles & Co. L P now owns 1,126,645 shares of the company’s stock worth $92,216,000 after acquiring an additional 24,665 shares during the last quarter. HighTower Advisors LLC grew its stake in shares of HealthEquity by 4.8% in the 4th quarter. HighTower Advisors LLC now owns 95,075 shares of the company’s stock worth $9,122,000 after acquiring an additional 4,370 shares in the last quarter. Geneva Capital Management LLC raised its holdings in shares of HealthEquity by 24.6% in the fourth quarter. Geneva Capital Management LLC now owns 1,048,903 shares of the company’s stock valued at $100,642,000 after purchasing an additional 206,894 shares during the last quarter. Finally, BNP Paribas Financial Markets lifted its position in shares of HealthEquity by 165.7% during the third quarter. BNP Paribas Financial Markets now owns 20,437 shares of the company’s stock valued at $1,673,000 after purchasing an additional 12,745 shares in the last quarter. Institutional investors and hedge funds own 99.55% of the company’s stock.

HealthEquity Trading Down 0.4 %

Shares of HealthEquity stock opened at $88.83 on Friday. The company has a quick ratio of 3.20, a current ratio of 3.20 and a debt-to-equity ratio of 0.51. HealthEquity has a 12-month low of $65.01 and a 12-month high of $115.59. The company has a market capitalization of $7.68 billion, a price-to-earnings ratio of 81.50, a PEG ratio of 1.60 and a beta of 0.62. The firm’s 50-day moving average price is $103.94 and its two-hundred day moving average price is $95.84.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.